Gene therapy has ushered in a new era of medical possibilities, offering groundbreaking treatments for debilitating and often fatal diseases. One of the most prominent examples is Lenmeldy (atidarsagene autotemcel), a gene therapy developed by Orchard Therapeutics and recently acquired by Kyowa
The modern healthcare landscape is rapidly evolving, with a growing emphasis on patient-centric care. Amidst this transformation, there is a compelling argument that integrating hospitality principles can substantially enhance the healthcare experience. The convergence of these two fields presents
In an era where technology drives significant improvements across various sectors, the collaboration between A.C.Camargo Cancer Center and Kyndryl stands out as a vital endeavor to enhance patient experience through cutting-edge IT infrastructure and observability solutions. By leveraging advanced
The 2023 annual survey of hospital inpatients by the Care Quality Commission (CQC) provides a revealing snapshot of patient experiences across 131 acute and specialist NHS trusts in England. Gathering insights from over 63,500 individuals who spent at least one night in a hospital, the survey
Cell and gene therapy hold tremendous promise for treating a wide array of diseases, including many that were previously considered untreatable. However, the high production costs associated with these advanced treatments pose a significant barrier to their widespread adoption. Automation emerges
Conjunctival hyperemia, characterized by redness, irritation, and watering of the eyes, continues to affect scores of people across Europe. This condition, which can significantly diminish one’s quality of life, poses a particular challenge due to the complexity of its causes and the side effects o
